Ufp Technologies (UFPT) Total Current Liabilities (2010 - 2026)
Ufp Technologies (UFPT) posted Total Current Liabilities of $77.0 million for Q1 2026, up 2.87% on a QoQ basis from $74.9 million in Q4 2025, and down 3.58% year-over-year from $79.9 million in Q1 2025.
Ufp Technologies (UFPT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $77.0 million for Q1 2026.
- Quarterly Total Current Liabilities fell 3.58% year-over-year to $77.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.0 million (down 3.58% YoY) and the FY2025 annual result came in at $74.9 million, down 1.88% from the prior year.
- Total Current Liabilities was $77.0 million for Q1 2026 at Ufp Technologies, up from $74.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $82.2 million in Q3 2025 and bottomed at $38.8 million in Q1 2022.
- A 5-year average of $62.8 million and a median of $57.4 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 205.97% — and 2026, when it retreated 3.58%.
- Ufp Technologies' Total Current Liabilities stood at $56.0 million in 2022, then increased by 4.02% to $58.2 million in 2023, then jumped by 31.07% to $76.3 million in 2024, then declined by 1.88% to $74.9 million in 2025, then gained by 2.87% to $77.0 million in 2026.
- Business Quant data shows UFPT's Total Current Liabilities at $77.0 million in Q1 2026, $74.9 million in Q4 2025, and $82.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 77.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.01 Mn |
| Dec 31, 2025 | 74.86 Mn |
| Sep 30, 2025 | 82.23 Mn |
| Jun 30, 2025 | 69.20 Mn |
| Mar 31, 2025 | 79.87 Mn |
| Dec 31, 2024 | 76.30 Mn |
| Sep 30, 2024 | 78.35 Mn |
| Jun 30, 2024 | 51.79 Mn |
| Mar 31, 2024 | 52.44 Mn |
| Dec 31, 2023 | 58.21 Mn |
| Sep 30, 2023 | 56.59 Mn |
| Jun 30, 2023 | 52.99 Mn |
| Mar 31, 2023 | 52.19 Mn |
| Dec 31, 2022 | 55.96 Mn |
| Sep 30, 2022 | 57.40 Mn |
| Jun 30, 2022 | 53.38 Mn |
| Mar 31, 2022 | 38.82 Mn |
| Dec 31, 2021 | 38.78 Mn |
| Sep 30, 2021 | 18.76 Mn |
| Jun 30, 2021 | 19.64 Mn |